Paper20043832
Anomalous constitutive Src kinase activity promotes B lymphoma survival and growth.
Ke J and 6 others. Mol Cancer, 2009. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Anomalous constitutive Src kinase activity promotes B lymphoma survival and growth. Papers, record 20043832. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20043832
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymphoma, B-Cell | Major topic |
| src-Family Kinases | Major topic |
| Animals | |
| Cell Survival | |
| Dasatinib | |
| Humans | |
| Mice | |
| Pyrimidines | |
| RNA, Small Interfering | |
| Thiazoles |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 5P01CA092372 | NCI NIH HHS | United States | P01CA092372 | PubMed and NIH |
Source NIH RePORTER
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15994925 | Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells. | Cancer Res | 2005 | https://conductscience.org/library/papers/15994925 | PubMed |
| 2 | 19290919 | Multiple roles of Lyn kinase in myeloid cell signaling and function. | Immunol Rev | 2009 | https://conductscience.org/library/papers/19290919 | PubMed |
| 3 | 19347849 | Isolation of whole mononuclear cells from peripheral blood and cord blood. | Curr Protoc Immunol | 2009 | https://conductscience.org/library/papers/19347849 | PubMed |
| 4 | 11786909 | Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. | Nat Med | 2002 | https://conductscience.org/library/papers/11786909 | PubMed |
| 5 | 18203007 | Src-family kinases in the development and therapy of Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia. | Leuk Lymphoma | 2008 | https://conductscience.org/library/papers/18203007 | PubMed |
| 6 | 8943396 | CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL. | J Immunol | 1996 | https://conductscience.org/library/papers/8943396 | PubMed |
| 7 | 15161356 | An association between oxidative stress and radiation-induced lymphomagenesis. | Radiat Res | 2004 | https://conductscience.org/library/papers/15161356 | PubMed |
| 8 | 18401881 | Overcoming kinase resistance in chronic myeloid leukemia. | Int J Biochem Cell Biol | 2008 | https://conductscience.org/library/papers/18401881 | PubMed |
| 9 | 9570540 | CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel. | J Immunol | 1998 | https://conductscience.org/library/papers/9570540 | PubMed |
| 10 | 16670274 | Cutting edge: constitutive B cell receptor signaling is critical for basal growth of B lymphoma. | J Immunol | 2006 | https://conductscience.org/library/papers/16670274 | PubMed |
| 11 | 15650771 | Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. | J Clin Invest | 2005 | https://conductscience.org/library/papers/15650771 | PubMed |
| 12 | 15851034 | The strength of receptor signaling is centrally controlled through a cooperative loop between Ca2+ and an oxidant signal. | Cell | 2005 | https://conductscience.org/library/papers/15851034 | PubMed |
| 13 | 15894265 | Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. | Cancer Cell | 2005 | https://conductscience.org/library/papers/15894265 | PubMed |
| 14 | 9636152 | Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9636152 | PubMed |
| 15 | 15902208 | An inhibitor of Bcl-2 family proteins induces regression of solid tumours. | Nature | 2005 | https://conductscience.org/library/papers/15902208 | PubMed |
| 16 | 16533761 | Treatment for advanced tumors: SRC reclaims center stage. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16533761 | PubMed |
| 17 | 17182546 | Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth. | J Immunol | 2007 | https://conductscience.org/library/papers/17182546 | PubMed |
| 18 | 15665117 | Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis. | Blood | 2005 | https://conductscience.org/library/papers/15665117 | PubMed |
| 19 | 7691606 | Elevation of cytosolic calcium is sufficient to induce growth inhibition in a B cell lymphoma. | Eur J Immunol | 1993 | https://conductscience.org/library/papers/7691606 | PubMed |
| 20 | 1709155 | The tyrosine kinase lck is critically involved in the growth transformation of human B lymphocytes. | J Biol Chem | 1991 | https://conductscience.org/library/papers/1709155 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37829571 | A Novel Peptide that Disrupts the Lck-IP3R Protein-Protein Interaction Induces Widespread Cell Death in Leukemia and Lymphoma. | Arch Microbiol Immunol | 2023 | https://conductscience.org/library/papers/37829571 | PubMed |
| 37308475 | Single-cell landscape of primary central nervous system diffuse large B-cell lymphoma. | Cell Discov | 2023 | https://conductscience.org/library/papers/37308475 | PubMed |
| 36446955 | The immunopathology of B lymphocytes during stroke-induced injury and repair. | Semin Immunopathol | 2023 | https://conductscience.org/library/papers/36446955 | PubMed |
| 35327462 | The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma. | Biomedicines | 2022 | https://conductscience.org/library/papers/35327462 | PubMed |
| 33639170 | TNF receptor-associated factor 3 restrains B-cell receptor signaling in normal and malignant B cells. | J Biol Chem | 2021 | https://conductscience.org/library/papers/33639170 | PubMed |
| 32171300 | Dasatinib reverses drug resistance by downregulating MDR1 and Survivin in Burkitt lymphoma cells. | BMC Complement Med Ther | 2020 | https://conductscience.org/library/papers/32171300 | PubMed |
| 30135222 | Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma. | mSphere | 2018 | https://conductscience.org/library/papers/30135222 | PubMed |
| 29340070 | A novel orally available Syk/Src/Jak2 inhibitor, SKLB-850, showed potent anti-tumor activities in B cell lymphoma (BCL) models. | Oncotarget | 2017 | https://conductscience.org/library/papers/29340070 | PubMed |
| 26096907 | Role of B cell receptor signaling in IL-10 production by normal and malignant B-1 cells. | Ann N Y Acad Sci | 2015 | https://conductscience.org/library/papers/26096907 | PubMed |
| 26020511 | Anti-cancer activity of withaferin A in B-cell lymphoma. | Cancer Biol Ther | 2015 | https://conductscience.org/library/papers/26020511 | PubMed |
| 25759025 | Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia. | Cancer Cell | 2015 | https://conductscience.org/library/papers/25759025 | PubMed |
| 25517315 | Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies. | MAbs | 2014 | https://conductscience.org/library/papers/25517315 | PubMed |
| 24186977 | Structure and function of Norrin in assembly and activation of a Frizzled 4-Lrp5/6 complex. | Genes Dev | 2013 | https://conductscience.org/library/papers/24186977 | PubMed |
| 24145282 | Antitumor effects of immunotoxins are enhanced by lowering HCK or treatment with SRC kinase inhibitors. | Mol Cancer Ther | 2014 | https://conductscience.org/library/papers/24145282 | PubMed |
| 22675518 | New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing. | PLoS One | 2012 | https://conductscience.org/library/papers/22675518 | PubMed |
| 22438981 | Modulation of β-catenin signaling by glucagon receptor activation. | PLoS One | 2012 | https://conductscience.org/library/papers/22438981 | PubMed |
Genes38
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20043832
GET https://conductscience.org/api/papers/v1/20043832/references?page=2